1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Lapo Alinari: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma Biospecimen Collection, Computed Tomography, Positron Emission Tomography - Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type | Phase 1 | Recruiting | Lapo Alinari | 18 | 2023-03-06 | 2026-02-27 |
Biopsy (1) · Magnetic Resonance Spectroscopy (1) · Specimen Handling (1)
United States (1)